Abstract:Ethnopharmacological relevance The natural anodyne Ligustilide (Lig), derived from Angelica sinensis (Oliv.) Diels and Ligusticum chuanxiong Hort., has been traditionally employed for its analgesic properties in the treatment of dysmenorrhea and migraine, and rheumatoid arthritis pain. Despite the existing reports on the correlation between TRP channels and the analgesic effects of Lig, a comprehensive understanding of their underlying mechanisms of action remains elusive. Aim of the study The objective of this study is to elucidate the mechanism of action of Lig on the analgesic target TRPA1 channel. Methods The therapeutic effect of Lig was evaluated in a rat acute soft tissue injury model. The analgesic target was identified through competitive inhibition of TRP channel agonists at the animal level, followed by Fluo-4/Ca 2+ imaging on live cells overexpressing TRP proteins. The potential target was verified through in-gel imaging, colocalization using a Lig-derived molecular probe, and a drug affinity response target stability assay. The binding site of Lig was identified through protein spectrometry and further analyzed using molecular docking, site-specific mutation, and multidisciplinary approaches. Results The administration of Lig effectively ameliorated pain and attenuated oxidative stress and inflammatory responses in rats with soft tissue injuries. Moreover, the analgesic effects of Lig were specifically attributed to TRPA1. Mechanistic studies have revealed that Lig directly activates TRPA1 by interacting with the linker domain in the pre-S1 region of TRPA1. Through metabolic transformation, 6,7-epoxyligustilide (EM-Lig) forms a covalent bond with Cys703 of TRPA1 at high concentrations and prolonged exposure time. This irreversible binding prevents endogenous electrophilic products from entering the cysteine active center of ligand-binding pocket of TRPA1, thereby inhibiting Ca 2+ influx through the channel opening and ultimately relieving pain. Conclusions Lig selectively modulates the TRPA1 channel in a bimodal manner via non-electrophilic/electrophilic metabolic conversion. The epoxidized metabolic intermediate EM-Lig exerts analgesic effects by irreversibly inhibiting the activation of TRPA1 on sensory neurons. These findings not only highlight the analgesic mechanism of Lig but also offer a novel nucleophilic attack site for the development of TRPA1 antagonists in the pre-S1 region.

A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel

Distinctive Drug Binding Sites and Gating Mechanisms of the Nociceptive Ion Channel TRPA1

Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin

A Structural Framework for the Polymodal Pain Sensor TRPV1

Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels.

Molecular Mechanism of TRPV1 Activation by Capsaicin

De Novo Design of Peptidic Positive Allosteric Modulators Targeting TRPV1 with Analgesic Effects

Irritant-evoked activation and calcium modulation of the TRPA1 receptor

Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action Via Cryogenic Electron Microscopy

Ligustilide covalently binds to Cys703 in the pre-S1 helix of TRPA1, blocking the opening of channel and relieving pain in rats with acute soft tissue injury

TRPA1 as a drug target--promise and challenges.

Selective potentiation of 2-APB-induced activation of TRPV1–3 channels by acid

Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective

Discovery of a Potent (4R,5S)-4-Fluoro-5-Methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist and its Methylene Phosphate Prodrug Guided By Molecular Modeling.

Structural basis of TRPV1 modulation by endogenous bioactive lipids

New natural agonists of the transient receptor potential Ankyrin 1 (TRPA1) channel

Structural Pharmacology of TRPV4 Antagonists

Bimodal voltage dependence of TRPA1: mutations of a key pore helix residue reveal strong intrinsic voltage-dependent inactivation

CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain

Molecular basis of TRPA1 regulation in nociceptive neurons. A review

Identification of the TRPA1 cannabinoid-binding site